GILDESS 1.5 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Gildess 1.5, and when can generic versions of Gildess 1.5 launch?
Gildess 1.5 is a drug marketed by Endo Operations and is included in one NDA.
The generic ingredient in GILDESS 1.5 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GILDESS 1.5?
- What are the global sales for GILDESS 1.5?
- What is Average Wholesale Price for GILDESS 1.5?
Summary for GILDESS 1.5
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | GILDESS 1.5 at DailyMed |
US Patents and Regulatory Information for GILDESS 1.5
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | GILDESS 1.5/30 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-21 | 077075-002 | Jul 24, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
